News|Videos|April 3, 2026

How Can Predictive Analytics Transform the Pharma Supply Chain?

Emily Gallo, SVP of OptiFreight® Logistics at Cardinal Health, discusses how predictive analytics and actionable benchmarking bridge the data-to-decision gap in pharma logistics.

In the first installment of her interview with Pharmaceutical Commerce, Emily Gallo, senior vice president and general manager of OptiFreight® Logistics at Cardinal Health discusses the critical intersection of predictive analytics and supply chain logistics.

In the modern pharma supply chain, the primary challenge is no longer a lack of information; it is the sheer volume of it. For many healthcare professionals and logistics teams, the transition from collecting massive datasets to executing timely, informed decisions remains a significant hurdle. As industry demands increase and resources tighten, the ability to predict "what’s around the corner" has become the differentiator between reactive firefighting and long-term operational resiliency. In an era where a single shipment delay can postpone a clinical trial or rare disease therapeutic delivery, the "data-to-decision" gap has moved from a back-office efficiency concern to a front-line strategic priority.

The stakes are particularly high within the specialized world of pharma logistics, where fragmented supplier networks and the high sensitivity of products—ranging from temperature-controlled drugs to irreplaceable tissue samples—leave little room for error. Against a backdrop of rising costs and labor shortages, supply chain leaders are increasingly being asked to do more with less, necessitating a shift from manual oversight to automated, predictive "control centers." This evolution isn't just about implementing new software; it's about redefining how logistics teams prioritize their limited time and resources to build a more sustainable, responsive network.

Gallo highlights how organizations are moving beyond basic data collection to implement actionable benchmarking and machine-learning tools. Throughout her conversation, she sheds light on how predictive insights do more than just protect the bottom line—they ensure the integrity of life-saving products and drive the long-term success of the health systems they support.